Literature DB >> 17132228

Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex.

Roxana I Sufan1, Michael Ohh.   

Abstract

ECV is an E3 ubiquitin ligase complex, which is composed of elongins B and C, Rbx1, Cul2, and the substrate-conferring von Hippel-Lindau (VHL) tumor-suppressor protein that targets the catalytic alpha subunit of hypoxia-inducible factor (HIF) for oxygen-dependent ubiquitin-mediated destruction. Mutations in VHL that compromise proper HIFalpha regulation through ECV have been documented in the majority of renal cell carcinomas, underscoring the significance of the VHL-HIF pathway in renal epithelial oncogenesis. Recent evidence has shown that the modification of Cul2 by the ubiquitin-like molecule NEDD8 increases the activity of ECV to ubiquitylate HIFalpha. However, the underlying mechanism responsible for the NEDD8-mediated induction of ECV function is unknown. Here, we demonstrate that oxygen-dependent recognition of HIFalpha by VHL triggers Rbx1-dependent neddylation of Cul2, which preferentially engages the E2 ubiquitin-conjugating enzyme UbcH5a. These events establish a central role for the neddylation of Cul2 in a previously unrecognized, temporally coordinated activation of ECV with the recruitment of its substrate HIFalpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132228      PMCID: PMC1716018          DOI: 10.1593/neo.06520

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  40 in total

1.  Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase in fission yeast.

Authors:  F Osaka; M Saeki; S Katayama; N Aida; A Toh-E; K Kominami; T Toda; T Suzuki; T Chiba; K Tanaka; S Kato
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Covalent modification of all members of human cullin family proteins by NEDD8.

Authors:  T Hori; F Osaka; T Chiba; C Miyamoto; K Okabayashi; N Shimbara; S Kato; K Tanaka
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

3.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

4.  Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).

Authors:  M Morimoto; T Nishida; R Honda; H Yasuda
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

5.  Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.

Authors:  M Ohh; C W Park; M Ivan; M A Hoffman; T Y Kim; L E Huang; N Pavletich; V Chau; W G Kaelin
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

6.  Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.

Authors:  K Iwai; K Yamanaka; T Kamura; N Minato; R C Conaway; J W Conaway; R D Klausner; A Pause
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha.

Authors:  M A Read; J E Brownell; T B Gladysheva; M Hottelet; L A Parent; M B Coggins; J W Pierce; V N Podust; R S Luo; V Chau; V J Palombella
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination.

Authors:  V N Podust; J E Brownell; T B Gladysheva; R S Luo; C Wang; M B Coggins; J W Pierce; E S Lightcap; V Chau
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

9.  The acidic tail domain of human Cdc34 is required for p27Kip1 ubiquitination and complementation of a cdc34 temperature sensitive yeast strain.

Authors:  Karen Block; Srikanth Appikonda; Horng-Ru Lin; Joanna Bloom; Michele Pagano; P Renee Yew
Journal:  Cell Cycle       Date:  2005-10-26       Impact factor: 4.534

10.  Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.

Authors:  K Tanimoto; Y Makino; T Pereira; L Poellinger
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

View more
  22 in total

1.  DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.

Authors:  Georg E Winter; Dennis L Buckley; Joshiawa Paulk; Justin M Roberts; Amanda Souza; Sirano Dhe-Paganon; James E Bradner
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

2.  Hypoxia-inducible factor α subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent.

Authors:  Ji-Hye Ryu; Shan-Hua Li; Hyoung-Sook Park; Jong-Wan Park; Byunglan Lee; Yang-Sook Chun
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

3.  SCCRO promotes glioma formation and malignant progression in mice.

Authors:  Stephen R Broderick; Benjamin J Golas; Duykhanh Pham; Christopher W Towe; Simon G Talbot; Andrew Kaufman; Sarina Bains; Laryssa A Huryn; Yoshihiro Yonekawa; Diane Carlson; Dolores Hambardzumyan; Yegnanarayana Ramanathan; Bhuvanesh Singh
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

4.  Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns.

Authors:  L C de Sá Rodrigues; K E Holmes; V Thompson; C M Piskun; S E Lana; M A Newton; T J Stein
Journal:  Vet Comp Oncol       Date:  2015-02-03       Impact factor: 2.613

5.  SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation.

Authors:  Alexander Y Kim; Claire C Bommeljé; Benjamin E Lee; Yoshihiro Yonekawa; Lydia Choi; Luc G Morris; Guochang Huang; Andrew Kaufman; Russel J H Ryan; Bing Hao; Y Ramanathan; Bhuvanesh Singh
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

6.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

7.  Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response.

Authors:  Stefan F Ehrentraut; Douglas J Kominsky; Louise E Glover; Eric L Campbell; Caleb J Kelly; Brittelle E Bowers; Amanda J Bayless; Sean P Colgan
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

Review 8.  VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment.

Authors:  W Kimryn Rathmell; Shufen Chen
Journal:  Expert Rev Anticancer Ther       Date:  2008-01       Impact factor: 4.512

9.  DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.

Authors:  Pardeep Heir; Roxana I Sufan; Samantha N Greer; Betty P Poon; Jeffrey E Lee; Michael Ohh
Journal:  Mol Cell Biol       Date:  2013-02-11       Impact factor: 4.272

10.  Hypoxia and Innate Immunity: Keeping Up with the HIFsters.

Authors:  Sean P Colgan; Glenn T Furuta; Cormac T Taylor
Journal:  Annu Rev Immunol       Date:  2020-01-21       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.